Ctrl Worx Watch List › Company
Bioethics Ltd: material weakness open at least 2,128 days
By Russell Tomoum, Ctrl Worx™. Built from its own SEC filings. How the Clock works.
Bioethics Ltd reported ineffective internal control over financial reporting because of a material weakness in 5 filings since Apr 15, 2021. The latest was its 10-K for the period ended Dec 31, 2024.
Ctrl Worx Watch List™ status
On the ClockStill filing, and no annual report of its own says the weakness is fixed.
Checked against SEC EDGAR: Oct 29, 2026 · Entry #10196
Causes the company named
Segregation of duties · 5Entity-level and governance · 4
Lack of segregation of duties due to same person serving as CEO and CFO without board oversight.
What the latest filing says
As such, our Chief Executive Officer/Chief Financial Officer does not believe the weakness has a material effect on the accuracy and completeness of our financial reporting and disclosure as included in this report or that the weakness constitutes a material weakness such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or deterred on a timely basis. Changes in Internal Control over Financial Reporting There was no change in our internal control over financial reporting during the year ended December 31, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. [...]
From the controls section of the 10-K filed Aug 13, 2025. Read the full filing on SEC EDGAR.
Company response: Bioethics Ltd can send a statement or a link to its remediation update to russell@ctrlworx.com. We post it here, unedited and dated.
Filings
| Filed | Form | Period | Controls | Causes | Filing |
|---|---|---|---|---|---|
| Aug 13, 2025 | 10-K | Dec 31, 2024 | Not effective | Segregation of duties | EDGAR |
| Apr 11, 2024 | 10-K | Dec 31, 2023 | Not effective | Segregation of duties; Entity-level and governance | EDGAR |
| Apr 17, 2023 | 10-K | Dec 31, 2022 | Not effective | Segregation of duties; Entity-level and governance | EDGAR |
| Apr 15, 2022 | 10-K | Dec 31, 2021 | Not effective | Segregation of duties; Entity-level and governance | EDGAR |
| Apr 15, 2021 | 10-K | Dec 31, 2020 | Not effective | Segregation of duties; Entity-level and governance | EDGAR |
Others on the Clock in the same industry
By SEC industry code: 6770, Blank Checks, then related codes.
- AIS Holdings Group, Inc. (AIDG) · open since Dec 2020 or earlier
- Allegro Merger Corp. · open since Dec 2020 or earlier
- Corner Growth Acquisition Corp. · open since Dec 2020 or earlier
- TechCom, Inc. (TCRI) · open since Dec 2020 or earlier
- Yale Transaction Finders, Inc. (YTFD) · open since Dec 2020 or earlier
Follow Bioethics Ltd for free
Get an email when Bioethics Ltd files a 10-K or 10-Q that reports a material weakness, or says its controls are effective again.
Want the next one the day it's filed?
MW Pro sends an alert the day a company you follow reports a material weakness or says it fixed one. Founding price $990 a year.
Join the MW Pro waitlistLook up any company in Controls Radar™Based on public SEC filings. Causes are grouped into standard categories by Ctrl Worx. The filings are the authority. Ctrl Worx is not affiliated with Bioethics Ltd or the SEC. Not investment advice. Why you can rely on the Watch List.